← Open Payments lookup

LYMARIE VILELLA: Open Payments

NPI 1205280484 · GROVELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,013 in 225 payments from 18 companies in 2025. Trend: 2023 $4,645 · 2024 $2,795 · 2025 $4,013

Food & beverage: $4,013
CompanyPaymentsAmount
ABBVIE INC.43$681
Neurocrine BioSciences, Inc.23$524
E.R. Squibb & Sons, L.L.C.15$316
Collegium Pharmaceutical, Inc.20$316
Corium, LLC12$247
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$235
Axsome Therapeutics, Inc.8$210
Vanda Pharmaceuticals Inc.8$199
Supernus Pharmaceuticals, Inc.17$190
Otsuka America Pharmaceutical, Inc.11$188

Products named: VRAYLAR, INGREZZA, COBENFY, Jornay PM, Azstarys, CAPLYTA, Auvelity, REXULTI.

Industry payments across FL — which companies pay providers there.